A detailed history of Jvl Associates LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jvl Associates LLC holds 543 shares of LLY stock, worth $427,987. This represents 0.19% of its overall portfolio holdings.

Number of Shares
543
Previous 584 7.02%
Holding current value
$427,987
Previous $528,000 8.9%
% of portfolio
0.19%
Previous 0.21%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$772.14 - $960.02 $31,657 - $39,360
-41 Reduced 7.02%
543 $481,000
Q2 2024

Jul 11, 2024

BUY
$724.87 - $909.04 $4,349 - $5,454
6 Added 1.04%
584 $528,000
Q1 2024

Apr 08, 2024

SELL
$592.2 - $792.28 $5,922 - $7,922
-10 Reduced 1.7%
578 $449,000
Q4 2023

Jan 17, 2024

BUY
$525.19 - $619.13 $94,534 - $111,443
180 Added 44.12%
588 $342,000
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $177,357 - $244,514
408 New
408 $219,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jvl Associates LLC Portfolio

Follow Jvl Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jvl Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jvl Associates LLC with notifications on news.